{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T04:12:25Z","timestamp":1775189545038,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T00:00:00Z","timestamp":1598227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T00:00:00Z","timestamp":1598227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["206470\/Z\/17\/Z"],"award-info":[{"award-number":["206470\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/19\/54\/34511"],"award-info":[{"award-number":["PG\/19\/54\/34511"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Comorbidity is common and has a substantial negative impact on the prognosis of patients with acute myocardial infarction (AMI). Whilst receipt of guideline-indicated treatment for AMI is associated with improved prognosis, the extent to which comorbidities influence treatment provision its efficacy is unknown. Therefore, we investigated the association between treatment provision for AMI and survival for seven common comorbidities.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We used data of 693,388 AMI patients recorded in the Myocardial Ischaemia National Audit Project (MINAP), 2003\u20132013. We investigated the association between comorbidities and receipt of optimal care for AMI (receipt of all eligible guideline-indicated treatments), and the effect of receipt of optimal care for comorbid AMI patients on long-term survival using flexible parametric survival models.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>A total of 412,809 [59.5%] patients with AMI had at least one comorbidity, including hypertension (302,388 [48.7%]), diabetes (122,228 [19.4%]), chronic obstructive pulmonary disease (COPD, 89,221 [14.9%]), cerebrovascular disease (51,883 [8.6%]), chronic heart failure (33,813 [5.6%]), chronic renal failure (31,029 [5.0%]) and peripheral vascular disease (27,627 [4.6%]).<\/jats:p>\n<jats:p>Receipt of optimal care was associated with greatest survival benefit for patients without comorbidities (HR 0.53, 95% CI 0.51\u20130.56) followed by patients with hypertension (HR 0.60, 95% CI 0.58\u20130.62), diabetes (HR 0.83, 95% CI 0.80\u20130.87), peripheral vascular disease (HR 0.85, 95% CI 0.79\u20130.91), renal failure (HR 0.89, 95% CI 0.84\u20130.94) and COPD (HR 0.90, 95% CI 0.87\u20130.94). For patients with heart failure and cerebrovascular disease, optimal care for AMI was not associated with improved survival.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Overall, guideline-indicated care was associated with improved long-term survival. However, this was not the case in AMI patients with concomitant heart failure or cerebrovascular disease. There is therefore a need for novel treatments to improve outcomes for AMI patients with pre-existing heart failure or cerebrovascular disease.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12916-020-01689-5","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T01:02:11Z","timestamp":1598230931000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Association of treatments for acute myocardial infarction and survival for seven common comorbidity states: a nationwide cohort study"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7200-9763","authenticated-orcid":false,"given":"Mohammad E.","family":"Yadegarfar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris P.","family":"Gale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatendashe B.","family":"Dondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris G.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin R.","family":"Cowie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlous","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,24]]},"reference":[{"issue":"3","key":"1689_CR1","doi-asserted-by":"publisher","first-page":"e1002501","DOI":"10.1371\/journal.pmed.1002501","volume":"15","author":"M Hall","year":"2018","unstructured":"Hall M, Dondo TB, Yan AT, Mamas MA, Timmis AD, Deanfield JE, Jernberg T, Hemingway H, Fox KAA, Gale CP. Multimorbidity and survival for patients with acute myocardial infarction in England and Wales: latent class analysis of a nationwide population-based cohort. PLoS Med. 2018;15(3):e1002501.","journal-title":"PLoS Med"},{"issue":"10159","key":"1689_CR2","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","volume":"392","author":"G. B. D. Causes of Death Collaborators","year":"2018","unstructured":"G. B. D. Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736\u201388.","journal-title":"Lancet"},{"issue":"3","key":"1689_CR3","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.amjcard.2015.04.047","volume":"116","author":"MA Mamas","year":"2015","unstructured":"Mamas MA, Fath-Ordoubadi F, Danzi GB, Spaepen E, Kwok CS, Buchan I, Peek N, de Belder MA, Ludman PF, Paunovic D, et al. Prevalence and impact of co-morbidity burden as defined by the Charlson co-morbidity index on 30-day and 1- and 5-year outcomes after coronary stent implantation (from the Nobori-2 study). Am J Cardiol. 2015;116(3):364\u201371.","journal-title":"Am J Cardiol"},{"issue":"16","key":"1689_CR4","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1001\/jama.2011.522","volume":"305","author":"T Jernberg","year":"2011","unstructured":"Jernberg T, Johanson P, Held C, Svennblad B, Lindback J, Wallentin L, Swedeheart\/Riks HIA. Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction. JAMA. 2011;305(16):1677\u201384.","journal-title":"JAMA"},{"issue":"2","key":"1689_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ahj.2015.05.007","volume":"170","author":"BR Shah","year":"2015","unstructured":"Shah BR, O'Brien EC, Roe MT, Chen AY, Peterson ED. The association of in-hospital guideline adherence and longitudinal postdischarge mortality in older patients with non-ST-segment elevation myocardial infarction. Am Heart J. 2015;170(2):273\u201380 e271.","journal-title":"Am Heart J"},{"key":"1689_CR6","first-page":"439","volume":"5","author":"HY Chen","year":"2013","unstructured":"Chen HY, Saczynski JS, McManus DD, Lessard D, Yarzebski J, Lapane KL, Gore JM, Goldberg RJ. The impact of cardiac and noncardiac comorbidities on the short-term outcomes of patients hospitalized with acute myocardial infarction: a population-based perspective. Clin Epidemiol. 2013;5:439\u201348.","journal-title":"Clin Epidemiol"},{"issue":"2","key":"1689_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/ehjqcco\/qcw003","volume":"2","author":"S Walker","year":"2016","unstructured":"Walker S, Asaria M, Manca A, Palmer S, Gale CP, Shah AD, Abrams KR, Crowther M, Timmis A, Hemingway H, et al. Long-term healthcare use and costs in patients with stable coronary artery disease: a population-based cohort using linked health records (CALIBER). Eur Heart J Qual Care Clin Outcomes. 2016;2(2):125\u201340.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"1689_CR8","unstructured":"UK Fact Sheet. https:\/\/www.bhf.org.uk\/-\/media\/files\/research\/heart-statistics\/bhf-cvd-statistics-uk-factsheet.pdf?la=en. Accessed 25 July 2019."},{"issue":"5","key":"1689_CR9","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/bjs.4913","volume":"92","author":"VEPP Lemmens","year":"2005","unstructured":"Lemmens VEPP, Janssen-Heijnen MLG, Verheij CDGW, Houterman S, Repelaer van Driel OJ, JWW C. Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. BJS. 2005;92(5):615\u201323.","journal-title":"BJS"},{"key":"1689_CR10","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.2147\/COPD.S136256","volume":"12","author":"NA Negewo","year":"2017","unstructured":"Negewo NA, Gibson PG, Wark PA, Simpson JL, McDonald VM. Treatment burden, clinical outcomes, and comorbidities in COPD: an examination of the utility of medication regimen complexity index in COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:2929\u201342.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1689_CR11","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.diabres.2018.05.031","volume":"142","author":"W Weng","year":"2018","unstructured":"Weng W, Liang Y, Kimball E, Hobbs T, Kong S. Trends in comorbidity burden and treatment patterns in type 2 diabetes: longitudinal data from a US cohort from 2006 to 2014. Diabetes Res Clin Pract. 2018;142:345\u201352.","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"1689_CR12","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1136\/heartjnl-2013-304588","volume":"100","author":"D Radovanovic","year":"2014","unstructured":"Radovanovic D, Seifert B, Urban P, Eberli FR, Rickli H, Bertel O, Puhan MA, Erne P, Investigators AP. Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002-2012. Heart. 2014;100(4):288\u201394.","journal-title":"Heart"},{"issue":"7","key":"1689_CR13","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1177\/2048872617729636","volume":"7","author":"S Rohrmann","year":"2018","unstructured":"Rohrmann S, Witassek F, Erne P, Rickli H, Radovanovic D. Treatment of patients with myocardial infarction depends on history of cancer. Eur Heart J Acute Cardiovasc Care. 2018;7(7):639\u201345.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"6","key":"1689_CR14","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1378\/chest.11-2032","volume":"141","author":"MS Stefan","year":"2012","unstructured":"Stefan MS, Bannuru RR, Lessard D, Gore JM, Lindenauer PK, Goldberg RJ. The impact of COPD on management and outcomes of patients hospitalized with acute myocardial infarction: a 10-year retrospective observational study. Chest. 2012;141(6):1441\u20138.","journal-title":"Chest"},{"issue":"6","key":"1689_CR15","first-page":"565","volume":"58","author":"BG Druss","year":"2001","unstructured":"Druss BG, Bradford WD, Rosenheck RA, Radford MJ, Krumholz HM. Quality of medical care and excess mortality in older patients with mental disorders. JAMA Psychiatry. 2001;58(6):565\u201372.","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"1689_CR16","doi-asserted-by":"publisher","first-page":"e0212398","DOI":"10.1371\/journal.pone.0212398","volume":"14","author":"M Ventura","year":"2019","unstructured":"Ventura M, Belleudi V, Sciattella P, Di Domenicantonio R, Di Martino M, Agabiti N, Davoli M, Fusco D. High quality process of care increases one-year survival after acute myocardial infarction (AMI): a cohort study in Italy. PLoS One. 2019;14(2):e0212398.","journal-title":"PLoS One"},{"issue":"1","key":"1689_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/jech-2016-207402","volume":"71","author":"OA Alabas","year":"2017","unstructured":"Alabas OA, Hall M, Dondo TB, Rutherford MJ, Timmis AD, Batin PD, Deanfield JE, Hemingway H, Gale CP. Long-term excess mortality associated with diabetes following acute myocardial infarction: a population-based cohort study. J Epidemiol Community Health. 2017;71(1):25\u201332.","journal-title":"J Epidemiol Community Health"},{"issue":"5","key":"1689_CR18","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/eurheartj\/ehl510","volume":"28","author":"RM Cubbon","year":"2007","unstructured":"Cubbon RM, Wheatcroft SB, Grant PJ, Gale CP, Barth JH, Sapsford RJ, Ajjan R, Kearney MT, Hall AS, Investigators obotE. Temporal trends in mortality of patients with diabetes mellitus suffering acute myocardial infarction: a comparison of over 3000 patients between 1995 and 2003. Eur Heart J. 2007;28(5):540\u20135.","journal-title":"Eur Heart J"},{"key":"1689_CR19","doi-asserted-by":"publisher","unstructured":"Wilkinson C, Weston C, Timmis A, Quinn T, Keys A, Gale CP. The Myocardial Ischaemia National Audit Project (MINAP). Eur Heart J Qual Care Clin Outcomes. 2020;6(1):19-22. https:\/\/doi.org\/10.1093\/ehjqcco\/qcz052.","DOI":"10.1093\/ehjqcco\/qcz052"},{"issue":"10","key":"1689_CR20","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1001\/jama.2016.10766","volume":"316","author":"M Hall","year":"2016","unstructured":"Hall M, Dondo TB, Yan AT, Goodman SG, Bueno H, Chew DP, Brieger D, Timmis A, Batin PD, Deanfield JE, et al. Association of clinical factors and therapeutic strategies with improvements in survival following non-ST-elevation myocardial infarction, 2003-2013. JAMA. 2016;316(10):1073\u201382.","journal-title":"JAMA"},{"issue":"5","key":"1689_CR21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1177\/2048872616647705","volume":"6","author":"TB Dondo","year":"2017","unstructured":"Dondo TB, Hall M, Timmis AD, Gilthorpe MS, Alabas OA, Batin PD, Deanfield JE, Hemingway H, Gale CP. Excess mortality and guideline-indicated care following non-ST-elevation myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2017;6(5):412\u201320.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"3","key":"1689_CR22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"M Roffi","year":"2016","unstructured":"Roffi M, Patrono C, Collet J-P, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267\u2013315.","journal-title":"Eur Heart J"},{"issue":"16","key":"1689_CR23","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1136\/hrt.2009.192328","volume":"96","author":"E Herrett","year":"2010","unstructured":"Herrett E, Smeeth L, Walker L, Weston C, Group MA. The Myocardial Ischaemia National Audit Project (MINAP). Heart. 2010;96(16):1264\u20137.","journal-title":"Heart"},{"issue":"13","key":"1689_CR24","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1093\/eurheartj\/ehx008","volume":"38","author":"O Bebb","year":"2017","unstructured":"Bebb O, Hall M, Fox KAA, Dondo TB, Timmis A, Bueno H, Schiele F, Gale CP. Performance of hospitals according to the ESC ACCA quality indicators and 30-day mortality for acute myocardial infarction: national cohort study using the United Kingdom Myocardial Ischaemia National Audit Project (MINAP) register. Eur Heart J. 2017;38(13):974\u201382.","journal-title":"Eur Heart J"},{"issue":"3","key":"1689_CR25","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/biomet\/63.3.581","volume":"63","author":"DB Rubin","year":"1976","unstructured":"Rubin DB. Inference and missing data. Biometrika. 1976;63(3):581\u201392.","journal-title":"Biometrika"},{"key":"1689_CR26","doi-asserted-by":"publisher","first-page":"l223","DOI":"10.1136\/bmj.l223","volume":"364","author":"CJ Taylor","year":"2019","unstructured":"Taylor CJ, Ord\u00f3\u00f1ez-Mena JM, Roalfe AK, Lay-Flurrie S, Jones NR, Marshall T, Hobbs FDR. Trends in survival after a diagnosis of heart failure in the United Kingdom 2000-2017: population based cohort study. Bmj. 2019;364:l223.","journal-title":"Bmj"},{"issue":"21","key":"1689_CR27","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV, Solomon SD, Inzucchi SE, K\u00f8ber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, B\u011blohl\u00e1vek J, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med. 2019;381(21):1995\u20132008.","journal-title":"N Engl J Med"},{"issue":"2","key":"1689_CR28","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2017","unstructured":"Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2017;39(2):119\u201377.","journal-title":"Eur Heart J"},{"key":"1689_CR29","doi-asserted-by":"publisher","first-page":"f4006","DOI":"10.1136\/bmj.f4006","volume":"347","author":"S Carville","year":"2013","unstructured":"Carville S, Harker M, Henderson R, Gray H. Acute management of myocardial infarction with ST-segment elevation: summary of NICE guidance. BMJ. 2013;347:f4006.","journal-title":"BMJ"},{"issue":"3","key":"1689_CR30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jacc.2016.04.053","volume":"68","author":"T Hasin","year":"2016","unstructured":"Hasin T, Gerber Y, Weston SA, Jiang R, Killian JM, Manemann SM, Cerhan JR, Roger VL. Heart failure after myocardial infarction is associated with increased risk of cancer. J Am Coll Cardiol. 2016;68(3):265\u201371.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1689_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/ehjqcco\/qcv011","volume":"1","author":"M Hall","year":"2015","unstructured":"Hall M, Alabas OA, Dondo TB, Jernberg T, Gale CP. Use of relative survival to evaluate non-ST-elevation myocardial infarction quality of care and clinical outcomes. Eur Heart J Qual Care Clin Outcomes. 2015;1(2):85\u201391.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"3","key":"1689_CR32","doi-asserted-by":"publisher","first-page":"e1002513","DOI":"10.1371\/journal.pmed.1002513","volume":"15","author":"J Tran","year":"2018","unstructured":"Tran J, Norton R, Conrad N, Rahimian F, Canoy D, Nazarzadeh M, Rahimi K. Patterns and temporal trends of comorbidity among adult patients with incident cardiovascular disease in the UK between 2000 and 2014: a population-based cohort study. PLoS Med. 2018;15(3):e1002513.","journal-title":"PLoS Med"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-01689-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-020-01689-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-01689-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T23:49:44Z","timestamp":1629762584000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-020-01689-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,24]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1689"],"URL":"https:\/\/doi.org\/10.1186\/s12916-020-01689-5","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,24]]},"assertion":[{"value":"10 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was not required under the National Health Service (NHS) research governance arrangements. The National Institute for Cardiovascular Outcomes Research (NICOR) which includes the Myocardial Ischaemia National Audit Project (MINAP) database (ref: NIGB: ECC 1-06 (d)\/2011) has support under section 251 of NHS Act 2006 to use patient information for medical research without consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MH has received research grants from the Wellcome Trust for the submitted work; CPG has received personal fees and non-financial support from AstraZeneca; research grants and personal fees from BMS; research grants, personal fees and non-financial support from Bayer; personal fees and non-financial support from Daiichy Sankyo; and personal fees and non-financial support from Vifor Pharma, outside the submitted work. CGW reports research grants from Bristol-Myer-Squibb, outside the submitted work; no other relationships or activities that could appear to have influenced the submitted work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"231"}}